Amedisys, Inc.
Registration details
Company overview
Amedisys, Inc. is a Delaware corporation, Delaware Division of Corporations file number 2414710 (the number validated against that register in its GLEIF LEI record 5299001RBS9GK9STN379), that provides home health, hospice and high-acuity in-home care in the United States. Its principal executive offices are at 3854 American Way, Suite A, Baton Rouge, Louisiana. According to its annual report on Form 10-K for 2024, the business was founded and incorporated in Louisiana in 1982 and was reincorporated as a Delaware corporation before its stock began trading publicly in August 1994.
Amedisys reports three segments: home health (skilled nursing and therapy delivered in patients’ homes), hospice (end-of-life care), and high acuity care, which delivers hospital-, palliative- and skilled-nursing-level care at home, largely through joint ventures with health systems. Because its patients are mostly elderly, Medicare is its principal payer. At 31 December 2024 the company reported approximately 19,000 employees in 519 care centres in 38 states and the District of Columbia, and more than 10.7 million patient visits a year.
For 2024 Amedisys, Inc. reported consolidated net service revenue of $2,348.3 million (2023: $2,236.4 million), of which home health contributed $1,490.5 million and hospice $825.8 million. These are consolidated figures.
Amedisys is no longer a listed company. Its common stock (ticker AMED) traded on the Nasdaq Global Select Market until 14 August 2025, when a merger agreed on 26 June 2023 closed and the Form 25 delisting notices were filed. On 25 August 2025 the company filed Form 15 to terminate its SEC registration and stopped publishing periodic reports. The U.S. Department of Justice and four states challenged the transaction; a proposed final judgment filed on 7 August 2025 and entered by the court on 10 December 2025 requires the divestiture of at least 164 home health and hospice locations in 19 states and imposes a $1.1 million civil penalty on Amedisys for a false Hart-Scott-Rodino certification.
Sources
- SEC EDGAR, Amedisys, Inc. Form 10-K for 2024, filed 27 February 2025: https://www.sec.gov/Archives/edgar/data/896262/000089626225000018/amed-20241231.htm (retrieved 2026-10-20)
- SEC EDGAR, Amedisys, Inc. Form 10-K/A (Amendment No. 2), filed 29 April 2025: https://www.sec.gov/Archives/edgar/data/896262/000089626225000036/amed-20241231.htm (retrieved 2026-10-20)
- SEC EDGAR, Amedisys, Inc. Form 8-K (merger closing), filed 14 August 2025: https://www.sec.gov/Archives/edgar/data/896262/000110465925078145/tm2523306d1_8k.htm (retrieved 2026-10-20)
- SEC EDGAR, Amedisys, Inc. Form 15-12G, filed 25 August 2025: https://www.sec.gov/Archives/edgar/data/896262/000119312525187814/d943324d1512g.htm (retrieved 2026-10-20)
- SEC EDGAR, Amedisys, Inc. Form 8-K (proposed final judgment), filed 7 August 2025: https://www.sec.gov/Archives/edgar/data/896262/000119312525175190/d18915d8k.htm (retrieved 2026-10-20)
- U.S. Department of Justice, “Court Approves Justice Department’s Settlement with UnitedHealth Group and Amedisys Merger”, 10 December 2025: https://www.justice.gov/opa/pr/court-approves-justice-departments-settlement-unitedhealth-group-and-amedisys-merger (retrieved 2026-10-20)
- GLEIF LEI record 5299001RBS9GK9STN379 (registration status LAPSED, last updated 13 July 2021): https://api.gleif.org/api/v1/lei-records/5299001RBS9GK9STN379 (retrieved 2026-10-20)
- Company fundamentals
- Corporate linkage & group structures
- Digitized company financials
- Firmographics — websites, social profiles, revenue and employee estimates
Officers
Directors and officers of Amedisys, Inc.
Amedisys, Inc. stopped filing with the SEC after its Form 15 of 25 August 2025, so no public list of its current directors and officers exists. The last complete list is in the Form 10-K/A filed on 29 April 2025. As of that date it named five executive officers: Richard Ashworth (President and Chief Executive Officer since 10 April 2023), Scott G. Ginn (Chief Operating Officer, Executive Vice President and Chief Financial Officer), Denise Bohnert (Chief Compliance Officer since September 2019), Jennifer Griffin (Chief Legal Officer, effective 4 November 2024) and Nick Muscato (Chief Strategy Officer since April 2022). Allyson D. Guidroz signed the Form 10-Q of 30 July 2025 as Principal Accounting Officer. The board before the merger had nine directors, and all of them resigned when the merger took effect on 14 August 2025. The new board has not been disclosed.
Recent officer changes
- 31 August 2024: Michael P. North ceased to be Chief Information Officer (Form 10-K/A, 29 April 2025).
- 14 August 2025: at the merger’s effective time, all nine directors resigned: Paul B. Kusserow, Julie D. Klapstein, Richard Ashworth, Vickie L. Capps, Molly Coye, Teresa L. Kline, Bruce D. Perkins, Jeffrey A. Rideout and Ivanetta D. Samuels (Form 8-K, Item 5.02, 14 August 2025).
- By 25 August 2025: Joshua L. Proffitt signed the Form 15 as President. Richard Ashworth had signed the closing 8-K on 14 August 2025 as President and Chief Executive Officer. No appointment date has been disclosed.
Data availability
Historical: the officer data comes from SEC filings that end in August 2025. Delaware’s register publishes no officer list, and the Louisiana geauxBIZ record could not be read because it is reCAPTCHA-protected. SEC filings do not disclose nationality or country of residence, so both are not disclosed. The “Residence” line on the cards below is not a filed fact.
Sources
- SEC EDGAR, Amedisys, Inc. Form 10-K/A (Amendment No. 2, Items 10–12), filed 29 April 2025: https://www.sec.gov/Archives/edgar/data/896262/000089626225000036/amed-20241231.htm (retrieved 2026-10-20)
- SEC EDGAR, Amedisys, Inc. Form 10-Q for the quarter ended 30 June 2025, filed 30 July 2025: https://www.sec.gov/Archives/edgar/data/896262/000089626225000065/amed-20250630.htm (retrieved 2026-10-20)
- SEC EDGAR, Amedisys, Inc. Form 8-K (merger closing, Item 5.02), filed 14 August 2025: https://www.sec.gov/Archives/edgar/data/896262/000110465925078145/tm2523306d1_8k.htm (retrieved 2026-10-20)
- SEC EDGAR, Amedisys, Inc. Form 15-12G, filed 25 August 2025: https://www.sec.gov/Archives/edgar/data/896262/000119312525187814/d943324d1512g.htm (retrieved 2026-10-20)
- SEC EDGAR full-text search, filings of CIK 0000896262: https://efts.sec.gov/LATEST/search-index?q=%22Muscato%22&ciks=0000896262 (retrieved 2026-10-20)
Group Structure
Group structure of Amedisys, Inc.
Amedisys, Inc. has been part of the UnitedHealth Group since 14 August 2025, when it survived a merger with Aurora Holdings Merger Sub Inc. as a wholly owned subsidiary of UnitedHealth Group Incorporated, a Delaware corporation. The ultimate parent is therefore UnitedHealth Group Incorporated (LEI 549300GHBMY8T5GXDE41). The immediate parent is not named in any filing reviewed. The closing Form 8-K describes Amedisys as a “wholly-owned subsidiary” in one place and an “indirect wholly-owned subsidiary” in another, so both readings are on the record. UnitedHealth Group’s Exhibit 21.1 for 2025 lists only its significant subsidiaries and does not name Amedisys, so its absence there says nothing about the relationship.
Amedisys’s last subsidiary list is Exhibit 21.1 to its Form 10-K for 2024 (filed 27 February 2025). That list names more than 170 US entities: corporations, limited liability companies, home health and hospice joint ventures (49%–70% owned), and the Contessa high-acuity care companies. The list is flat, so it does not show which entities are held directly and which indirectly. Under the court’s final judgment of 10 December 2025, at least 164 home health and hospice locations in 19 states had to be divested. The filings reviewed do not say which of the listed entities were affected, so the 2024 list may no longer be current.
Verified corporate relationships
| Entity | Country | Registration number | Relationship | Ownership | Status | Information date |
|---|---|---|---|---|---|---|
| UnitedHealth Group Incorporated | United States (Delaware) | LEI 549300GHBMY8T5GXDE41 | Ultimate parent | 100% (wholly owned; direct or indirect not settled) | Listed on NYSE | 14 Aug 2025 |
| Aurora Holdings Merger Sub Inc. | United States (Delaware) | Not disclosed | Historical: UnitedHealth Group merger subsidiary that merged into Amedisys | Not applicable | Merged out 14 Aug 2025 | 14 Aug 2025 |
| Amedisys Holding, L.L.C. | United States (Louisiana) | Not disclosed | Subsidiary (“wholly-owned subsidiary of the Company”; co-borrower under the credit agreement terminated 14 Aug 2025) | 100% (as described in the filing) | Not verified | 14 Aug 2025 |
| Amedisys Home Health, a Lawrence Medical Center Partner, L.L.C. | United States (Delaware) | Not disclosed | Joint venture | 66.67% | Not verified | 27 Feb 2025 |
| UMC Home Health and Hospice, an Amedisys Partner, L.L.C. | United States (Texas) | Not disclosed | Joint venture | 50% | Not verified | 27 Feb 2025 |
Recent structural changes
- 26 June 2023: Amedisys terminated its 3 May 2023 merger agreement with Option Care Health, Inc. (paying a $106 million termination fee) and signed the merger agreement with UnitedHealth Group (Form 8-K, 26 June 2023).
- 14 August 2025: the merger closed and Amedisys became a wholly owned subsidiary of UnitedHealth Group (Form 8-K, 14 August 2025).
- 10 December 2025: the court entered the final judgment requiring divestiture of at least 164 home health and hospice locations (U.S. Department of Justice).
Data availability
Partial: the parent is established by filings, but the intermediate holding chain is unpublished, and the subsidiary list predates both the merger and the court-ordered divestitures. Delaware and Louisiana publish no ownership linkage.
Sources
- SEC EDGAR, Amedisys, Inc. Form 8-K (merger closing), filed 14 August 2025: https://www.sec.gov/Archives/edgar/data/896262/000110465925078145/tm2523306d1_8k.htm (retrieved 2026-10-20)
- SEC EDGAR, Amedisys, Inc. Exhibit 21.1 to Form 10-K for 2024, filed 27 February 2025: https://www.sec.gov/Archives/edgar/data/896262/000089626225000018/a202410-kexhibit211.htm (retrieved 2026-10-20)
- SEC EDGAR, Amedisys, Inc. Form 8-K (merger agreement; Option Care Health termination), filed 26 June 2023: https://www.sec.gov/Archives/edgar/data/896262/000110465923074547/tm2319648d1_8k.htm (retrieved 2026-10-20)
- SEC EDGAR, UnitedHealth Group Incorporated Exhibit 21.1 to Form 10-K for 2025, filed 2 March 2026: https://www.sec.gov/Archives/edgar/data/731766/000073176626000062/unhex21112312025.htm (retrieved 2026-10-20)
- U.S. Department of Justice press release, 10 December 2025: https://www.justice.gov/opa/pr/court-approves-justice-departments-settlement-unitedhealth-group-and-amedisys-merger (retrieved 2026-10-20)
- GLEIF LEI record 549300GHBMY8T5GXDE41: https://api.gleif.org/api/v1/lei-records/549300GHBMY8T5GXDE41 (retrieved 2026-10-20)
Frequently asked questions
What does Amedisys, Inc. do?
Amedisys, Inc. is a Delaware corporation (file number 2414710), based in Baton Rouge, Louisiana, that provides home health, hospice and high-acuity in-home care in the United States. It was founded in Louisiana in 1982 and reincorporated in Delaware before its 1994 public listing.
Who owns Amedisys, Inc.?
Since 14 August 2025 Amedisys has had one stockholder of record. It is a wholly owned subsidiary of UnitedHealth Group Incorporated, and every public share was converted into $101 in cash. The fund holdings shown on this page describe shares that were cancelled in the merger, and their percentages are not supported by any filing.
Who is Amedisys, Inc.'s UBO (Ultimate Beneficial Owner)?
No natural-person beneficial owner of Amedisys appears on the public record. It is wholly owned by UnitedHealth Group Incorporated, a widely held company listed on the NYSE, and the intermediate holding company is not named in the filings.
What is Amedisys, Inc.'s company registration number?
Amedisys, Inc. is a Delaware corporation, Delaware Division of Corporations file number 2414710, as validated in its GLEIF LEI record (5299001RBS9GK9STN379, now lapsed). It filed with the SEC under CIK 896262 until August 2025.
Is Amedisys, Inc. still an active company?
It still exists as a wholly owned subsidiary of UnitedHealth Group, having survived the merger of 14 August 2025. Its Delaware register status was not checked, and it no longer files with the SEC.
When was Amedisys, Inc. incorporated?
The business was founded and incorporated in Louisiana in 1982 and reincorporated as a Delaware corporation before its stock began trading publicly in August 1994.
What is Amedisys, Inc.'s registered address?
Its principal executive offices are at 3854 American Way, Suite A, Baton Rouge, Louisiana.
What legal structure is Amedisys, Inc. registered as?
It is a Delaware corporation. Its stock is no longer listed, and it has been wholly owned by UnitedHealth Group since 14 August 2025.
What is Amedisys, Inc.'s revenue?
For 2024 Amedisys reported consolidated net service revenue of $2,348.3 million, up from $2,236.4 million in 2023 (Form 10-K for 2024). It has published no later annual figures.
Is Amedisys, Inc. listed on a stock exchange?
Amedisys is no longer listed. Its common stock (AMED) was delisted from the Nasdaq Global Select Market when its merger closed on 14 August 2025, and it filed Form 15 on 25 August 2025 to end its SEC registration.
Who are the officers/directors of Amedisys, Inc.?
Amedisys has not published an officer list since it deregistered in August 2025. All nine directors resigned at the merger on 14 August 2025, and Joshua L. Proffitt signed the Form 15 of 25 August 2025 as President. Its April 2025 filing named Richard Ashworth as President and Chief Executive Officer.
Does Amedisys, Inc. have a parent company or subsidiaries?
Amedisys has been part of the UnitedHealth Group since 14 August 2025, with UnitedHealth Group Incorporated as ultimate parent. Its last filed subsidiary list (February 2025) named more than 170 US entities, and some of its operations had to be divested under a court judgment entered on 10 December 2025.
What did the Justice Department settlement require of Amedisys?
The final judgment entered on 10 December 2025 requires the divestiture of at least 164 home health and hospice locations in 19 states and imposes a $1.1 million civil penalty on Amedisys for a false Hart-Scott-Rodino certification.
Why did the Option Care Health merger not go ahead?
On 26 June 2023 Amedisys terminated its 3 May 2023 merger agreement with Option Care Health, Inc., paying a $106 million termination fee, and signed the merger agreement with UnitedHealth Group.
How large is Amedisys?
At 31 December 2024 it reported approximately 19,000 employees in 519 care centres in 38 states and the District of Columbia, and more than 10.7 million patient visits a year.